Management of Nulliparous Pelvic Organ Prolapse

Why Nulliparous Prolapse Is Special

• Connective tissue disorders - Ehlers-Danlos syndrome (hypermobile type) and Marfan syndrome are strongly associated; these women lack normal collagen architecture in the endopelvic fascia and cardinal/uterosacral ligament complex
• Altered collagen subtypes - An abnormal ratio of collagen type I to type III weakens ligamentous attachments independent of delivery
• Congenital levator ani deficiency or wide urogenital hiatus
• Chronic straining (from constipation, heavy lifting, high-impact athletic activity) - sustained Valsalva transfers intra-abdominal pressure directly to the pelvic floor
• Spinal cord injury or neuropathy causing loss of levator ani tone
• MRI studies confirm that visible levator ani defects are not found in nulliparous women (only in primiparous women after vaginal delivery), so prolapse here arises from connective tissue failure, not muscle injury - Campbell-Walsh-Wein Urology, p. 3416

Initial Assessment

1. Full history - onset, symptoms (vaginal bulge is the most specific symptom for POP), bowel/bladder dysfunction, sexual function, desire for future fertility, activity level
2. POP-Q staging - the validated Pelvic Organ Prolapse Quantification system allows objective staging (Stages I-IV) and tracking over time
3. Compartment identification - anterior (cystocele), apical (uterine/vaginal vault), posterior (rectocele/enterocele)
4. Screen for underlying cause - joint hypermobility, skin elasticity, family history pointing to inherited connective tissue disorder
5. Urodynamics / bladder evaluation if urinary symptoms present; note that as prolapse extends beyond the hymen, stress urinary incontinence (SUI) paradoxically decreases due to urethral kinking, but may unmask after repair
6. Bowel evaluation if defecatory symptoms present; correlation between bowel symptoms and POP severity is weak, and rectocele should only be repaired if the patient has specific splinting symptoms

• Berek & Novak's Gynecology, p. 1593-1594

Nonsurgical (Conservative) Management

Pelvic Floor Muscle Training (PFMT)

• Goals: prevent worsening prolapse, reduce symptom burden, increase pelvic floor strength and endurance, avoid/delay surgery
• Most effective for Stage I-II prolapse; response rate decreases once prolapse extends beyond the vaginal introitus
• A randomized trial (POPPY trial) showed women receiving individualized one-to-one PFMT reported significantly fewer prolapse symptoms at 12 months vs. lifestyle advice leaflet alone
• Biofeedback augments PFMT in patients with impaired defecatory function and rectocele
• Berek & Novak's Gynecology, p. 1616

Lifestyle Modification

• Weight management (reduce chronic intra-abdominal pressure)
• Treat constipation aggressively (stool softeners, fiber, osmotic laxatives) to reduce straining
• Activity modification - heavy weightlifting and high-impact sports increase prolapse risk; referral to pelvic physiotherapist for activity guidance
• A 2025 systematic review (PMID 39918585) specifically examined the influence of powerlifting and weightlifting on female pelvic floor dysfunction, underscoring the relevance of exercise counseling in this population

Pessary

• Women who wish to avoid surgery or who desire future fertility
• Pregnancy-related prolapse
• Bridging therapy until surgical correction
• Two categories: support pessaries (ring with diaphragm - for Stage I-II) and space-filling pessaries (Gellhorn - for Stage III-IV)
• A pessary trial also has diagnostic value: if symptoms improve with a pessary, those symptoms are more likely attributable to POP and more likely to improve with surgical repair
• Relative contraindications: vaginal length ≤6 cm, wide vaginal introitus (reduces retention), sexual activity preference, prior pelvic surgery
• Berek & Novak's Gynecology, p. 1617

Surgical Management

1. Young age and active lifestyle
2. Fertility preservation (if desired)
3. Underlying connective tissue defect (tissue quality may be poor - compensatory approaches may outperform restorative ones)
4. Long life expectancy (durability of repair is paramount)

Apical Compartment (Most Important)

Uterine Preservation - Critical Consideration in Nulliparous Women

• The uterus plays a passive role in prolapse; hysterectomy has never been proven necessary to correct the underlying apical support defect
• Uterine-preserving (hysteropexy) procedures reduce operative time, blood loss, and mesh erosion risk vs. hysterectomy-based repair, with similar short-term prolapse recurrence
• The SUPeR trial (randomized trial of vaginal hysterectomy + uterosacral suspension vs. vaginal mesh hysteropexy) was designed to directly address this question
• Studies show 60% of women would decline hysterectomy if offered an equally effective alternative; 36% prefer uterine preservation when efficacy is comparable
• Uterine-sparing transvaginal options: Manchester procedure, uterosacral hysteropexy, sacrospinous hysteropexy
• Abdominal/laparoscopic: sacral hysteropexy (mesh to sacrum with uterus preserved)

• Abnormal uterine bleeding or cervical pathology
• High risk of uterine/cervical malignancy
• Patient preference for hysterectomy
• Campbell-Walsh-Wein Urology, Table 124.14; Berek & Novak's, p. 1622

Anterior Compartment (Cystocele)

• Anterior vaginal colporrhaphy - plication of the pubocervical fibromuscular layer; suitable for central defects
• Paravaginal repair - addresses lateral attachment defects (arcus tendineus fasciae pelvis); can be performed vaginally or abdominally
• Important: anterior repair must always be accompanied by apical suspension; isolated anterior repair without apical fixation has unacceptably high recurrence

Posterior Compartment (Rectocele/Enterocele)

• Traditional posterior colporrhaphy - midline plication of the rectovaginal fibromuscular layer; be cautious about over-plication causing dyspareunia in sexually active young women
• Site-specific defect repair - identified and repaired individually (transverse, midline, or lateral defects)
• Enterocele repair: peritoneal sac ligation + fascial closure; McCall or Halban technique intraperitoneally

Mesh Considerations

• Synthetic mesh augmentation (especially for anterior and posterior compartments) was associated with serious FDA safety warnings (2011, 2019 - transvaginal mesh for POP)
• In young, sexually active nulliparous women with potential for future pregnancy, native tissue repair is generally preferred over transvaginal mesh for anterior/posterior compartments
• Sacrocolpopexy mesh (abdominal route) has a different and more favorable safety profile than transvaginal mesh, and remains acceptable
• Berek & Novak's, p. 1611

Summary Algorithm

Nulliparous prolapse diagnosed
         |
    Assess stage, compartment, fertility wishes, activity level
         |
Stage I-II, mild symptoms ──────► PFMT + lifestyle modification + pessary if needed
         |                                    |
         |                         Observe, re-assess at 6-12 months
         |
Stage II-III+ or failed conservative ──► Surgical planning
         |
    Desires future fertility?
    YES ──► Uterine-preserving procedure
           (sacrospinous hysteropexy / sacral hysteropexy / Manchester)
    NO  ──► Hysterectomy + apical suspension
           (sacrocolpopexy preferred in young women for durability)
         |
    Address anterior/posterior defects concurrently
    Native tissue preferred unless clear indication for mesh

Special Considerations

• Post-surgical pregnancy: Vaginal delivery after hysteropexy or apical repair risks re-prolapse; counsel re: elective caesarean section after surgical repair if future pregnancy planned
• Connective tissue disorder screening: All young nulliparous women with POP warrant evaluation for Ehlers-Danlos/Marfan; these patients may have poorer tissue quality and higher recurrence rates regardless of technique
• Activity counseling: Post-repair activity restriction, avoidance of heavy lifting, and pelvic floor physiotherapy reduce recurrence risk
• Oestrogen: In premenopausal nulliparous women topical oestrogen has limited role; a 2023 Cochrane review (PMID 37431855) found insufficient evidence that oestrogen prevents or treats POP in postmenopausal women

• Berek & Novak's Gynecology, Chapter on Pelvic Organ Prolapse (pp. 1593-1664)
• Campbell-Walsh-Wein Urology, Chapters 62, 68 (Pelvic Organ Prolapse, pp. 3405-3416)
• SUPeR Trial design; PMID 39918585 (weightlifting/pelvic floor SysRev 2025); PMID 37431855 (Cochrane oestrogen for POP 2023)